BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37553515)

  • 21. The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis.
    Powers BD; Fulp W; Dhahri A; DePeralta DK; Ogami T; Rothermel L; Permuth JB; Vadaparampil ST; Kim JK; Pimiento J; Hodul PJ; Malafa MP; Anaya DA; Fleming JB
    Ann Surg; 2021 Dec; 274(6):e564-e573. PubMed ID: 31851004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.
    Murphy MM; Simons JP; Hill JS; McDade TP; Chau Ng S; Whalen GF; Shah SA; Harrison LH; Tseng JF
    Cancer; 2009 Sep; 115(17):3979-90. PubMed ID: 19514091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Area deprivation and rurality impact overall survival and adjuvant therapy administration in patients with pancreatic ductal adenocarcinoma (PDAC).
    Pothuri V; Zárate Rodriguez JG; Kasting C; Leigh N; Hawkins WG; Sanford DE; Fields RC
    HPB (Oxford); 2023 Dec; 25(12):1545-1554. PubMed ID: 37626007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
    Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
    J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Location in the Pancreatic Tail Is Associated with Decreased Likelihood of Receiving Chemotherapy for Pancreatic Adenocarcinoma.
    Drake JA; Fleming AM; Behrman SW; Glazer ES; Deneve JL; Yakoub D; Tsao MW; Dickson PV
    J Gastrointest Surg; 2022 Oct; 26(10):2136-2147. PubMed ID: 35768717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
    Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
    BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.
    Lim JE; Chien MW; Earle CC
    Ann Surg; 2003 Jan; 237(1):74-85. PubMed ID: 12496533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urban/rural patterns in receipt of treatment for non-small cell lung cancer among black and white Medicare beneficiaries, 2000-2003.
    Steele CB; Pisu M; Richardson LC
    J Natl Med Assoc; 2011 Aug; 103(8):711-8. PubMed ID: 22046848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection.
    Ellis RJ; Ho JW; Schlick CJR; Merkow RP; Bentrem DJ; Bilimoria KY; Yang AD
    Ann Surg Oncol; 2020 Mar; 27(3):909-918. PubMed ID: 31691112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting Surgical Margins in Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer Undergoing Resection.
    Ren W; Xourafas D; Ashley SW; Clancy TE
    Am Surg; 2022 Dec; 88(12):2899-2906. PubMed ID: 33861651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between geographic residence and US adolescent and young adult cancer stage and survival.
    Johnson KJ; Wang X; Barnes JM; Delavar A
    Cancer; 2021 Oct; 127(19):3640-3650. PubMed ID: 34236080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database.
    Hamad A; Underhill J; Ansari A; Thayaparan V; Cloyd JM; Li Y; Pawlik TM; Tsung A; Abushahin L; Ejaz A
    Surgery; 2022 Jun; 171(6):1464-1470. PubMed ID: 35115154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C; Vrugt B; Flury R; Schraml P; Knippschild U; Wild P; Hoerstrup S; Henne-Bruns D; Wuerl P; Graf R; Breitenstein S; Bond G; Beerenwinkel N; Grochola LF
    JAMA Surg; 2019 Jun; 154(6):e190484. PubMed ID: 30942874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparities in Stage-Specific Guideline-Concordant Cancer-Directed Treatment for Patients with Pancreatic Adenocarcinoma.
    Hamad A; DePuccio M; Reames BN; Dave A; Kurien N; Cloyd JM; Shen C; Pawlik TM; Tsung A; McAlearney AS; Ejaz A
    J Gastrointest Surg; 2021 Nov; 25(11):2889-2901. PubMed ID: 33768427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residence in Rural Areas of the United States and Lung Cancer Mortality. Disease Incidence, Treatment Disparities, and Stage-Specific Survival.
    Atkins GT; Kim T; Munson J
    Ann Am Thorac Soc; 2017 Mar; 14(3):403-411. PubMed ID: 28118039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based analysis of urban-rural disparities in advanced pancreatic cancer management and outcomes.
    Canale TD; Cho H; Cheung WY
    Med Oncol; 2018 Jul; 35(8):116. PubMed ID: 29974267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy.
    Fulop DJ; Zylberberg HM; Wu YL; Aronson A; Labiner AJ; Wisnivesky J; Cohen DJ; Sigel KM; Lucas AL
    JAMA Netw Open; 2023 Mar; 6(3):e234254. PubMed ID: 36951863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy.
    Sugawara T; Rodriguez Franco S; Sherman S; Kirsch MJ; Colborn K; Ishida J; Grandi S; Al-Musawi MH; Gleisner A; Schulick RD; Del Chiaro M
    JAMA Oncol; 2023 Mar; 9(3):316-323. PubMed ID: 36480190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rural Disparities in Lung Cancer-directed Surgery: A Medicare Cohort Study.
    Loehrer AP; Chen L; Wang Q; Colla CH; Wong SL
    Ann Surg; 2023 Mar; 277(3):e657-e663. PubMed ID: 36745766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.